We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$76.9B
AUM Growth
+$11.3B
Cap. Flow
+$9.16B
Cap. Flow %
11.92%
Top 10 Hldgs %
31.81%
Holding
7,054
New
709
Increased
2,754
Reduced
2,613
Closed
569

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$376M
2
AAPL icon
Apple
AAPL
+$264M
3
STJ
St Jude Medical
STJ
+$263M
4
MSFT icon
Microsoft
MSFT
+$260M
5
BABA icon
Alibaba
BABA
+$172M

Sector Composition

Rank Sector Weight
1 Technology 5.56%
2 Healthcare 4.73%
3 Financials 4.3%
4 Consumer Discretionary 3.31%
5 Energy 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZB icon
5751
La-Z-Boy
LZB
$1.6B
$3K ﹤0.01%
131
-288
-69% -$7.54K
MDGL icon
5752
Madrigal Pharmaceuticals
MDGL
$10.7B
$3K ﹤0.01%
371
+369
+18,450% +$4.43K
MHO icon
5753
M/I Homes
MHO
$3.81B
$3K ﹤0.01%
165
-6,571
-98% -$124K
MMSI icon
5754
Merit Medical Systems
MMSI
$4.97B
$3K ﹤0.01%
129
-2,129
-94% -$40.9K
MYGN icon
5755
CALL
Myriad Genetics
MYGN
$293M
$3K ﹤0.01%
100
-8,700
-99% -$302K
NBTB icon
5756
NBT Bancorp
NBTB
$2.73B
$3K ﹤0.01%
119
-1,025
-90% -$28.8K
OTTR icon
5757
Otter Tail
OTTR
$3.76B
$3K ﹤0.01%
78
-16
-17% -$481
IFLN
5758
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$3K ﹤0.01%
+148
New +$2.68K
PSTV icon
5759
Plus Therapeutics
PSTV
$25M
0
QURE icon
5760
uniQure
QURE
$3.05B
$3K ﹤0.01%
340
+200
+143% +$2.39K
REK icon
5761
ProShares Short Real Estate
REK
$11.7M
$3K ﹤0.01%
+100
New +$3.6K
REW icon
5762
Proshares UltraShort Technology
REW
$3.48M
$3K ﹤0.01%
1
RIGL icon
5763
CALL
Rigel Pharmaceuticals
RIGL
$685M
$3K ﹤0.01%
140
+60
+75% +$1.49K
SANM icon
5764
CALL
Sanmina
SANM
$10.1B
$3K ﹤0.01%
100
-100
-50% -$2.5K
SCHL icon
5765
Scholastic
SCHL
$773M
$3K ﹤0.01%
67
TCBK icon
5766
TriCo Bancshares
TCBK
$1.84B
$3K ﹤0.01%
110
+78
+244% +$2.1K
TMP icon
5767
Tompkins Financial
TMP
$1.42B
$3K ﹤0.01%
40
-1,637
-98% -$107K
VAC icon
5768
Marriott Vacations Worldwide
VAC
$3.38B
$3K ﹤0.01%
42
-2,080
-98% -$130K
WSFS icon
5769
WSFS Financial
WSFS
$4.1B
$3K ﹤0.01%
108
-6,738
-98% -$229K
ZSL icon
5770
PUT
ProShares UltraShort Silver
ZSL
$66.2M
$3K ﹤0.01%
1
-14
-93% -$91.5K
ATYR
5771
aTyr Pharma
ATYR
$46.8M
$3K ﹤0.01%
67
+55
+458% +$2.56K
ATRI
5772
DELISTED
Atrion Corp
ATRI
$3K ﹤0.01%
6
-202
-97% -$82K
AVTA
5773
PUT
DELISTED
Avantax, Inc. Common Stock
AVTA
$3K ﹤0.01%
300
-3,100
-91% -$24.4K
ZYNE
5774
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$3K ﹤0.01%
+371
New +$3.1K
VRAY
5775
DELISTED
ViewRay, Inc.
VRAY
$3K ﹤0.01%
+685
New +$3.13K

Similar funds

Barclays's Q2 2016 Portfolio in Review

As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.

  • Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
  • Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
  • Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
  • Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
  • Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
  • Barclays opened 709 new positions and closed 569 in Q2 2016.
  • Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.